These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19958201)
1. Detection of a rare mutation in an Iranian family: codons 37/38/39 (7 bp deletion). Zadeh-Vakili A; Eshghi P Hemoglobin; 2009; 33(6):523-7. PubMed ID: 19958201 [TBL] [Abstract][Full Text] [Related]
2. β-Thalassemia mutations found during 1 year of prenatal diagnoses in Fars Province, Iran. Rahiminejad MS; Zeinali S; Afrasiabi A; Valeshabad AK Hemoglobin; 2011; 35(4):331-7. PubMed ID: 21797700 [TBL] [Abstract][Full Text] [Related]
3. Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family. Haghi M; Feizi AA; Harteveld CL; Pouladi N; Feizi MA Hemoglobin; 2009; 33(1):75-80. PubMed ID: 19205978 [TBL] [Abstract][Full Text] [Related]
4. A family with the 619 bp deletion on the beta-globin gene found in Kerman Province, Iran. Saleh-Gohari N; Mashizi AK Hemoglobin; 2009; 33(6):515-8. PubMed ID: 19958199 [TBL] [Abstract][Full Text] [Related]
5. beta-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Haghi M; Khorshidi S; Hosseinpour Feizi MA; Pouladi N; Hosseinpour Feizi AA Hemoglobin; 2009; 33(2):109-14. PubMed ID: 19373586 [TBL] [Abstract][Full Text] [Related]
6. Profile of β-thalassemia and its prenatal diagnosis in Khorasan-e-Jonobi Province, Iran. Miri-Moghaddam E; Zadeh-Vakili A Hemoglobin; 2012; 36(5):456-63. PubMed ID: 22920564 [TBL] [Abstract][Full Text] [Related]
7. Identification of three novel mutations [-41 (A>C), codon 24 (-G), and IVS-I-109 (-T)], in a study of beta-thalassemia alleles in the Isfahan region of Iran. Salehi R; Fisher CA; Bignell PA; Eslami G; Old JM Hemoglobin; 2010; 34(1):115-20. PubMed ID: 20113296 [TBL] [Abstract][Full Text] [Related]
8. Sistani population: a different spectrum of β-thalassemia mutations from other ethnic groups of Iran. Miri-Moghaddam E; Zadeh-Vakili A; Nikravesh A; Sistani SS; Naroie-Nejad M Hemoglobin; 2013; 37(2):138-47. PubMed ID: 23437895 [TBL] [Abstract][Full Text] [Related]
9. Distribution of beta-thalassemia mutations in the northern provinces of Iran. Derakhshandeh-Peykar P; Akhavan-Niaki H; Tamaddoni A; Ghawidel-Parsa S; Naieni KH; Rahmani M; Babrzadeh F; Dilmaghani-Zadeh M; Farhud DD Hemoglobin; 2007; 31(3):351-6. PubMed ID: 17654072 [TBL] [Abstract][Full Text] [Related]
10. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients. El-Gawhary S; El-Shafie S; Niazi M; Aziz M; El-Beshlawy A Hemoglobin; 2007; 31(1):63-9. PubMed ID: 17365006 [TBL] [Abstract][Full Text] [Related]
11. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran. Kiani AA; Mortazavi Y; Zeinali S; Shirkhani Y Hemoglobin; 2007; 31(3):343-9. PubMed ID: 17654071 [TBL] [Abstract][Full Text] [Related]
12. Rare and unexpected mutations among Iranian beta-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Najmabadi H; Pourfathollah AA; Neishabury M; Sahebjam F; Krugluger W; Oberkanins C Haematologica; 2002 Oct; 87(10):1113-4. PubMed ID: 12368169 [No Abstract] [Full Text] [Related]
13. Is the frameshift codons 8/9 (+G) [FSC 8/9 (+G)] beta-thalassemia mutation, detected by the polymerase chain reaction-amplification refractory mutation system, really FSC 8/9 (+G)? Haghi M; Feizi AA; Feizi MA; Pouladi N; Basak AN Hemoglobin; 2009; 33(3):279-82. PubMed ID: 19657845 [TBL] [Abstract][Full Text] [Related]
14. A double heterozygote for (deltabeta)0-thalassemia and codons 41/42 (-TTCT) behaves as a homozygote for the frameshift mutation in a Chinese family. Liao C; Feng Q; Li J; Huang Y; Li D Hemoglobin; 2007; 31(3):397-400. PubMed ID: 17654080 [TBL] [Abstract][Full Text] [Related]
15. Haplotypes linked to three rare beta-thalassemia mutations, originally reported in Tunisia. Bibi A; Messaoud T; Fattoum S Hemoglobin; 2006; 30(2):175-81. PubMed ID: 16798642 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel deletion causing beta-thalassemia major in an Afghan family. Gallienne AE; Iberson NM; Dréau HM; Jackson H; Bignell PA; Old JM; Schuh A; Henderson SJ Hemoglobin; 2010; 34(1):110-4. PubMed ID: 20113295 [TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of beta-thalassemia in Egypt: implementing accurate high-tech methods did not reflect much on the outcome. Elgawhary S; Elbaradie Sahar MY; Rashad WM; Mosaad M; Abdalla MA; Ezzat G; Wali YA; Elbeshlawy A Pediatr Hematol Oncol; 2008 Sep; 25(6):541-8. PubMed ID: 18728973 [TBL] [Abstract][Full Text] [Related]
18. A novel 26 bp deletion [HBB: c.20_45del26bp] in exon 1 of the β-globin gene causing β-thalassemia major. Edison ES; Venkatesan RS; Govindanattar SD; George B; Shaji RV Hemoglobin; 2012; 36(1):98-102. PubMed ID: 22233277 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of a Chinese pedigree with beta-thalassemia intermedia. Huang G; Jiang WL; Rong KB; Li YX; Luo XL; Meng JX; Yu XY Hemoglobin; 2010 Jan; 34(2):179-83. PubMed ID: 20353356 [TBL] [Abstract][Full Text] [Related]
20. Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hussein G; Fawzy M; Serafi TE; Ismail EF; Metwally DE; Saber MA; Giansily M; Schved JF; Pissard S; Martinez PA Hemoglobin; 2007; 31(1):49-62. PubMed ID: 17365005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]